A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, ...
Preliminary data has been released from three new studies concerning the likelihood of patients developing stomach paralysis, or gastroparesis, from taking GLP-1 agonists, CNN reported. Two of the ...
Hosted on MSN53m
Scientists develop 'new Ozempic' to reduce appetite with nauseaThe numbers are based on users or healthcare workers informing the regulator of adverse reactions to the drugs, known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback